Daphne Haim Langford

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

Tarsier Pharma Ltd. operates as a research and development company focusing on development of drug candidates in the field of ophthalmology. It develops a novel treatment for uveitis based on technology inspired by biomimetics. The company was founded by Daphne Haim-Langford in February 2016 and is headquartered in Zichron Yaacov, Israel.

Van Leer Xenia Ventures (Van Leer Xenia Ventures) is a venture capital firm founded in 2006. The firm is headquartered in Jerusalem, Israel.

keepMED Ltd. manufactures innovative devices for treating obstructive sleep apnea. It offers keePAP, a wearable device that comprises of a lightweight unobtrusive nasal interface and a miniature battery-operated control unit that is used for the treatment of obstructive sleep apnea. The company was founded by Rapoport Alex and is headquartered in Rishon Le Zion, Israel.

Tarsier Pharma Ltd. operates as a research and development company focusing on development of drug candidates in the field of ophthalmology. It develops a novel treatment for uveitis based on technology inspired by biomimetics. The company was founded by Daphne Haim-Langford in February 2016 and is headquartered in Zichron Yaacov, Israel.

Tarsier Pharma Ltd. operates as a research and development company focusing on development of drug candidates in the field of ophthalmology. It develops a novel treatment for uveitis based on technology inspired by biomimetics. The company was founded by Daphne Haim-Langford in February 2016 and is headquartered in Zichron Yaacov, Israel.